Literature DB >> 15885644

Armed CD4+ Th1 effector cells and activated macrophages participate in bile duct injury in murine biliary atresia.

Cara L Mack1, Rebecca M Tucker, Ronald J Sokol, Brian L Kotzin.   

Abstract

Biliary atresia (BA) is an inflammatory cholangiopathy of infancy. A proposed mechanism regarding the pathogenesis of BA is that of a virus-induced, immune-mediated injury to bile ducts. The rotavirus (RRV)-induced murine model of BA was utilized to determine the hepatic inflammatory response related to ductal obstruction and if the immune response recapitulated human BA. One week after infection, there was a significant increase in liver CD4(+) T cells producing IFN-gamma and in macrophages producing TNF-alpha. The intrahepatic pattern of inflammation evolved rapidly from an initial predominant CD4(+) Th1 cellular response to a subsequent influx of activated macrophages producing TNF-alpha and iNOS. This immune response persisted despite viral clearance and was representative of the hepatic immune profile present in human BA. Utilization of the murine model of BA yielded mechanistic data that can provide much needed insight into the role played by different arms of the immune system related to the pathogenesis of human BA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885644      PMCID: PMC1950158          DOI: 10.1016/j.clim.2005.01.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  27 in total

1.  Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia.

Authors:  M Davenport; C Gonde; R Redkar; G Koukoulis; M Tredger; G Mieli-Vergani; B Portmann; E R Howard
Journal:  J Pediatr Surg       Date:  2001-07       Impact factor: 2.545

2.  Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions.

Authors:  Chih-Te Wu; Jason P Eiserich; Aftab A Ansari; Ross L Coppel; Sripriya Balasubramanian; Christopher L Bowlus; M Eric Gershwin; Judy Van De Water
Journal:  Hepatology       Date:  2003-10       Impact factor: 17.425

3.  A histological study of extrahepatic biliary atresia.

Authors:  S Gosseye; J B Otte; R De Meyer; P Maldague
Journal:  Acta Paediatr Belg       Date:  1977 Apr-Jun

4.  Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst--the concept of infantile obstructive cholangiopathy.

Authors:  B H Landing
Journal:  Prog Pediatr Surg       Date:  1974

Review 5.  Etiopathogenesis of biliary atresia.

Authors:  R J Sokol; C Mack
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

6.  Biliary atresia and reovirus type 3 infection.

Authors:  R Morecki; J H Glaser; S Cho; W F Balistreri; M S Horwitz
Journal:  N Engl J Med       Date:  1982-08-19       Impact factor: 91.245

7.  Immunological gap in the infectious animal model for biliary atresia.

Authors:  G Czech-Schmidt; W Verhagen; P Szavay; J Leonhardt; C Petersen
Journal:  J Surg Res       Date:  2001-11       Impact factor: 2.192

8.  Clearance of interleukin 2 from the blood of normal and T cell-depleted mice.

Authors:  P F Mühlradt; H G Opitz
Journal:  Eur J Immunol       Date:  1982-11       Impact factor: 5.532

9.  Obstruction of extrahepatic bile ducts by lymphocytes is regulated by IFN-gamma in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Kathleen M Campbell; Gregg E Sabla; Alexander Miethke; Greg Tiao; Monica M McNeal; Richard L Ward; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

10.  Biliary atresia is associated with CD4+ Th1 cell-mediated portal tract inflammation.

Authors:  Cara L Mack; Rebecca M Tucker; Ronald J Sokol; Frederick M Karrer; Brian L Kotzin; Peter F Whitington; Stephen D Miller
Journal:  Pediatr Res       Date:  2004-05-05       Impact factor: 3.756

View more
  50 in total

1.  Gene expression profile of the infective murine model for biliary atresia.

Authors:  Johannes Leonhardt; Martin Stanulla; Reinhard von Wasielewski; Julia Skokowa; Joachim Kübler; Benno M Ure; Claus Petersen
Journal:  Pediatr Surg Int       Date:  2006-01       Impact factor: 1.827

2.  Corticosteroid treatment in biliary atresia: Tonic or toast?

Authors:  Ronald J Sokol
Journal:  Hepatology       Date:  2007-12       Impact factor: 17.425

3.  Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia.

Authors:  Barrett H Barnes; Rebecca M Tucker; Fabian Wehrmann; Doug G Mack; Yoshiyuki Ueno; Cara L Mack
Journal:  Liver Int       Date:  2008-11-15       Impact factor: 5.828

4.  Swiss outcomes in biliary atresia: are there lessons to be learned?

Authors:  Ronald J Sokol
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-03       Impact factor: 2.839

5.  Elevated Th17 cells accompanied by decreased regulatory T cells and cytokine environment in infants with biliary atresia.

Authors:  Ying Yang; Yong-jun Liu; Shao-tao Tang; Li Yang; Jun Yang; Guo-qing Cao; Jing-hui Zhang; Xin-xin Wang; Yong-zhong Mao
Journal:  Pediatr Surg Int       Date:  2013-12       Impact factor: 1.827

6.  RRAS: A key regulator and an important prognostic biomarker in biliary atresia.

Authors:  Rui Zhao; Hao Li; Chun Shen; Shan Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

Review 7.  Biliary atresia: will blocking inflammation tame the disease?

Authors:  Kazuhiko Bessho; Jorge A Bezerra
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

Review 8.  Pathogenesis of biliary atresia: defining biology to understand clinical phenotypes.

Authors:  Akihiro Asai; Alexander Miethke; Jorge A Bezerra
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-05-26       Impact factor: 46.802

Review 9.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

10.  Staging of biliary atresia at diagnosis by molecular profiling of the liver.

Authors:  Katie Moyer; Vivek Kaimal; Cristina Pacheco; Reena Mourya; Huan Xu; Pranavkumar Shivakumar; Ranajit Chakraborty; Marepalli Rao; John C Magee; Kevin Bove; Bruce J Aronow; Anil G Jegga; Jorge A Bezerra
Journal:  Genome Med       Date:  2010-05-13       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.